UA108989C2 - Pyrimidinones as p13k inhibitors - Google Patents

Pyrimidinones as p13k inhibitors

Info

Publication number
UA108989C2
UA108989C2 UAA201200882A UAA201200882A UA108989C2 UA 108989 C2 UA108989 C2 UA 108989C2 UA A201200882 A UAA201200882 A UA A201200882A UA A201200882 A UAA201200882 A UA A201200882A UA 108989 C2 UA108989 C2 UA 108989C2
Authority
UA
Ukraine
Prior art keywords
pyrimidinones
inhibitors
disorders
pi3k
activity
Prior art date
Application number
UAA201200882A
Other languages
Ukrainian (uk)
Inventor
Брайан В. Меткаф
Original Assignee
Инсайт Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Инсайт Корпорейшн filed Critical Инсайт Корпорейшн
Priority claimed from PCT/US2010/040150 external-priority patent/WO2011008487A1/en
Publication of UA108989C2 publication Critical patent/UA108989C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

У цьому винаході представлені піримідинони які модулюють активність фосфоінозитид-3-кіназ (РІ3K), і є придатними для лікування захворювань, пов'язаних з активністю РІ3K, включаючи, наприклад, запальні порушення, імунопатологічні порушення, рак і інші розлади.The present invention provides pyrimidinones that modulate the activity of phosphoinositide-3-kinases (PI3K) and are suitable for the treatment of diseases associated with PI3K activity, including, for example, inflammatory disorders, immunopathological disorders, cancer and other disorders.

UAA201200882A 2009-06-29 2010-06-28 Pyrimidinones as p13k inhibitors UA108989C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22116009P 2009-06-29 2009-06-29
PCT/US2010/040150 WO2011008487A1 (en) 2009-06-29 2010-06-28 Pyrimidinones as pi3k inhibitors

Publications (1)

Publication Number Publication Date
UA108989C2 true UA108989C2 (en) 2015-07-10

Family

ID=52449852

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201200882A UA108989C2 (en) 2009-06-29 2010-06-28 Pyrimidinones as p13k inhibitors

Country Status (2)

Country Link
EC (1) ECSP12011628A (en)
UA (1) UA108989C2 (en)

Also Published As

Publication number Publication date
ECSP12011628A (en) 2012-02-29

Similar Documents

Publication Publication Date Title
EA201270100A1 (en) Pyrimidinones as PI3K inhibitors
AU2018236800B2 (en) DNA-PK inhibitors
GEP20156229B (en) 5-alkynyl-pyrimidines
ECSP14013148A (en) DERIVATIVES OF AZETIDINIL FENIL, PIRIDIL OR PIRAZINIL CARBOXAMIDA AS JAK INHIBITORS
EA201490541A1 (en) HETEROCYCLILAMINES AS PI3K INHIBITORS
EA201290894A1 (en) AZETIDINE DERIVATIVES OF PIPERIDIN-4-ILA AS JAK1 INHIBITORS
IN2014KN02601A (en)
EA201590850A1 (en) TRICYCLIC CONDENSED TIOPHENE DERIVATIVES AS INHIBITORS JAK
MX2014005928A (en) Heterocyclic inhibitors of glutaminase.
MY184101A (en) Indoles
TN2012000081A1 (en) Compounds and compositions as protein kinase inhibitors
EA201200473A1 (en) SUBSTITUTED (HETEROARILMETHYL) THIOGIDANTOINES
EA201200323A1 (en) COMPOUNDS AND COMPOSITIONS AS PROTEINKINASE INHIBITORS
EA201170832A1 (en) PURINE CONNECTIONS
UA112795C2 (en) BICYCLIC PYRAZINONE DERIVATIVES
EA201101241A1 (en) TREATMENT OF LEUKEMIA AND CHRONIC MYELOPROLIFERATIVE DISEASES BY ERP3 Antibodies
EP2563794A4 (en) Inhibitors of protein tyrosine kinase activity and use thereof to treat ophthalmic disorders
CR20140289A (en) DERIVATIVES OF QUINOLINE AS INHIBITORS OF THE ENZYME PDE10A
UA108989C2 (en) Pyrimidinones as p13k inhibitors
MY159995A (en) Pyrimidinyl indole compounds
EA201270727A1 (en) PURINE CONNECTIONS
UA112552C2 (en) HETEROCYCLYLAMINS AS PI3K INHIBITORS
UA110978C2 (en) Azetidinylphenyl, pyridyl or pyrazinylcarboxamide derivatives as JAK inhibitors
UA110108C2 (en) Azetidine derivatives of piperidine-4-yl as JAK1 inhibitors
CY1115351T1 (en) Pyrimidinones as PI3K Inhibitors